VAERS Explorer
Back to explore

Report #2878370

Received Dec 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
MA
Recovered
Unknown
Vaccinated
Nov 17, 2025
Onset
Nov 17, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATIONUNK——

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

16 Year Old Received HEPLISAV-B; Initial report received on 17-Nov-2025. A pharmacist reported that a 16-year-old male received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history or concomitant medications were reported. On 17-Nov-2025, the patient received a dose of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. The patient was 16 years old at the time of vaccination. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.